Q1 devastated by PVC crisis; recovery conditional on normalization

Specialty revenue ₹177 Cr (33% of total); actual EBITDA growth ~20% supported by call disclosures

Q1 only achieved ₹34.5 Cr PAT, heavily lifted by ₹34 Cr tax benefit. Underlying profitability weak (EBITDA down 28% YoY, OPM 6.6%)

Recovery conditional on: import duties stay, VCM prices remain elevated, no new geopolitical shocks. July showed mixed results (stock-carrying, duties delayed). Probability of Q2 breakeven in Basic Chemicals remains uncertain

Specialty Chemicals revenue grew only 6% QoQ despite 59% CPVC volume growth, indicates pricing pressure and margin compression (33.6% → 29.1%)

This is a direct downward revision from ₹400 Cr guidance 'a couple of years back.' PVC/CPVC spread contraction permanent, not cyclical

CFO explicitly: prior ₹400 Cr target (2 yrs back, CPVC margin 40%) now revised to ₹300 Cr steady-state due to PVC/CPVC spread compression from structural commodity dynamics, not temporary disruptions.

FY27 full legacy debt payoff + net debt-free by end-FY27 reaffirmed. Debt repay ~₹135 Cr vs capex borrowing 'shade higher' per CFO. Treasury discipline: maintain 5–10% of revenue as cash.

First step in 5-year growth cycle: SIOP expansion 30→45k TPM (₹7k tons Phase 1, completion Q4 FY28) + captive power at Sahupuram (Q4 FY28). Target 20% minimum incremental ROCE.

Management expects Q2 breakeven 'if normalcy settles'; CFO cautious about July (stock-carrying + delayed duty reinstatement). No absolute guidance, hedged by market uncertainty.

CFO: Synthetic Rutile inventory liquidation in Q4 was the main single effect; PVC production shutdown couple of days; not calculated precise split.

CFO: Explained dynamic PVC/CPVC spread due to volatile PVC pricing, import duty removal. SIOP margins robust 35%+. Mix dynamic; will normalize as PVC/CPVC spreads settle.

CFO: Directional swing estimate ₹50–55 Cr QoQ (from Q4 profit to Q1 loss at contribution level). Fixed cost allocation prevents product-level precision.

CFO: Yes, acknowledged smallest quintile. Offset by: solar investments, now announced power plant capex for efficiency gains on Basic Chemicals to remain competitive.

CFO: No. ₹400 Cr was 'a couple years back' when CPVC margin ~40%. PVC/CPVC contraction means steady-state ~₹300 Cr. Must see how things shape up for all 4 quarters.

CEO: MIP floor at ₹80; currently offers ₹820–860 (much higher). China has logistics issues; expect prices to stay at these levels at least Q2. With VCM corrected, expect 'reasonably well' in Basic Chemicals.

CFO: Synthetic Rutile EBITDA much better annually. Back-ended customer mix to higher-priced buyers. Expect delta in profitability coming quarters.

CEO: Natural supply shortage. VCM from Asian producers sourced crude feedstock Middle East; conflict forced force majeure cuts → lower availability. Spot purchases from China at higher prices.

CEO: Cannot strategize for war; hope one-time. Asian producers locked into Middle East. CFO: Migrated from single producer Qatar to global distributor across Asia for supply resilience; prices hard to hedge.

CEO: No merchant VCM seller in India; all imported. Integration impractical unless 5x PVC expansion (unplanned). Already communicated unlikely to expand Basic Chemicals unless specialty augmentation needed.

CFO: Focused on chemistry balancing and related products. SIOP has high entry barriers, moat. Not exhausted opportunity in related chemistry; new segments too risky without existing moat.

CFO: VCM is gaseous; storage only helps 10–15 days additional. Supply-chain play, not derisking. Migration to global distributor already derisked supply significantly; pricing in wars cannot be hedged.

Based on Q2+ normalization assumption; if PVC/VCM spreads stay volatile or new shocks occur, target at risk

Subject to PVC/CPVC spread dynamics; Q1 showed 29% vs prior-year 33% due to lag effects

July was mixed (stock-carrying, duty delays); no absolute commitment, heavily conditional

CFO accepted structural margin compression from PVC/CPVC spread contraction; not cyclical rebound

Disciplined ROCE target 20% minimum; treasury maintain 5–10% cash of revenue; will borrow 'shade higher' than ₹135 Cr repayment

VCM/PVC spread swung ₹50–55 Cr Q1 due to West Asia crisis. Realized prices fell despite revenue growth. Scale disadvantage means highest breakeven prices—vulnerable to margin compression cycles.

CFO acknowledged smallest-quintile capacity in PVC (100k tons), caustic (90k tons), soda ash (implied). Cost of production inversely proportional to scale; highest breakeven prices among peers. Limits pricing power during downturns.

EBITDA target cut from ₹400 Cr (stated 2 yrs back, CPVC margin 40%) to ₹300 Cr steady-state. Prior guidance repeatedly missed due to commodity volatility. Q2 recovery contingent on assumptions (normalcy holds, duties stay) that proved fragile Q1.

₹250 Cr capex program (SIOP Phase 1 7k tons + power plant) targeted Q4 FY28 commissioning. SIOP market demand not guaranteed at current margins (35–36%). Phase 2 (8k tons) contingent on Phase 1 success. Supply chain delays or market softness could slow payback.

VCM 100% imported; previously sourced Qatar (single), now global distributor. Middle East conflict forced migration to spot purchases from China. If new conflicts emerge (India-Pakistan, Taiwan strait, escalating Middle East), VCM supply & pricing unpredictable. No backward integration planned (would require 5x PVC capacity).